General Information of Drug Off-Target (DOT) (ID: OTWZKY4L)

DOT Name PR domain zinc finger protein 14 (PRDM14)
Synonyms EC 2.1.1.-; PR domain-containing protein 14
Gene Name PRDM14
Related Disease
Advanced cancer ( )
Cervical cancer ( )
Chronic pancreatitis ( )
Colorectal carcinoma ( )
Germ cell tumor ( )
leukaemia ( )
Leukemia ( )
Lung cancer ( )
Matthew-Wood syndrome ( )
Neoplasm ( )
Neoplasm of testis ( )
Non-small-cell lung cancer ( )
Pancreatitis ( )
Schizophrenia ( )
Seminoma ( )
T-cell acute lymphoblastic leukaemia ( )
Teratoma ( )
Testicular germ cell tumor ( )
Triple negative breast cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Childhood acute lymphoblastic leukemia ( )
Pancreatic cancer ( )
UniProt ID
PRD14_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.1.1.-
Pfam ID
PF21549 ; PF00096
Sequence
MALPRPSEAVPQDKVCYPPESSPQNLAAYYTPFPSYGHYRNSLATVEEDFQPFRQLEAAA
SAAPAMPPFPFRMAPPLLSPGLGLQREPLYDLPWYSKLPPWYPIPHVPREVPPFLSSSHE
YAGASSEDLGHQIIGGDNESGPCCGPDTLIPPPPADASLLPEGLRTSQLLPCSPSKQSED
GPKPSNQEGKSPARFQFTEEDLHFVLYGVTPSLEHPASLHHAISGLLVPPDSSGSDSLPQ
TLDKDSLQLPEGLCLMQTVFGEVPHFGVFCSSFIAKGVRFGPFQGKVVNASEVKTYGDNS
VMWEIFEDGHLSHFIDGKGGTGNWMSYVNCARFPKEQNLVAVQCQGHIFYESCKEIHQNQ
ELLVWYGDCYEKFLDIPVSLQVTEPGKQPSGPSEESAEGYRCERCGKVFTYKYYRDKHLK
YTPCVDKGDRKFPCSLCKRSFEKRDRLRIHILHVHEKHRPHKCSTCGKCFSQSSSLNKHM
RVHSGDRPYQCVYCTKRFTASSILRTHIRQHSGEKPFKCKYCGKSFASHAAHDSHVRRSH
KEDDGCSCSICGKIFSDQETFYSHMKFHEDY
Function
Transcription factor that has both positive and negative roles on transcription. Required for the maintenance of embryonic stem cell identity and the reacquisition of pluripotency in somatic cells. May play an essential role in germ cell development at 2 levels: the reacquisition of potential pluripotency, including SOX2 up-regulation, and successful epigenetic reprogramming, characterized by EHMT1 repression. Its association with CBFA2T2 is required for the functions in pluripotency and germ cell formation. Directly up-regulates the expression of pluripotency gene POU5F1 through its proximal enhancer. Binds to the DNA consensus sequence 5'-GGTC[TC]CTAA-3'.
Tissue Specificity Expressed in embryonic stem cells. Tends to be overexpressed in breast cancer (at protein level).
Reactome Pathway
Transcriptional regulation of pluripotent stem cells (R-HSA-452723 )

Molecular Interaction Atlas (MIA) of This DOT

23 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Cervical cancer DISFSHPF Strong Altered Expression [2]
Chronic pancreatitis DISBUOMJ Strong Biomarker [3]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [4]
Germ cell tumor DIS62070 Strong Altered Expression [5]
leukaemia DISS7D1V Strong Biomarker [1]
Leukemia DISNAKFL Strong Biomarker [1]
Lung cancer DISCM4YA Strong Biomarker [6]
Matthew-Wood syndrome DISA7HR7 Strong Altered Expression [3]
Neoplasm DISZKGEW Strong Biomarker [4]
Neoplasm of testis DISK4XHT Strong Genetic Variation [7]
Non-small-cell lung cancer DIS5Y6R9 Strong Biomarker [8]
Pancreatitis DIS0IJEF Strong Altered Expression [3]
Schizophrenia DISSRV2N Strong Genetic Variation [9]
Seminoma DIS3J8LJ Strong Biomarker [5]
T-cell acute lymphoblastic leukaemia DIS17AI2 Strong Biomarker [1]
Teratoma DIS6ICY4 Strong Altered Expression [5]
Testicular germ cell tumor DIS5RN24 Strong Genetic Variation [10]
Triple negative breast cancer DISAMG6N Strong Biomarker [11]
Breast cancer DIS7DPX1 moderate Biomarker [12]
Breast carcinoma DIS2UE88 moderate Biomarker [12]
Childhood acute lymphoblastic leukemia DISJ5D6U Limited Biomarker [13]
Pancreatic cancer DISJC981 Limited Altered Expression [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 23 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of PR domain zinc finger protein 14 (PRDM14). [14]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of PR domain zinc finger protein 14 (PRDM14). [19]
------------------------------------------------------------------------------------
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin affects the expression of PR domain zinc finger protein 14 (PRDM14). [15]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of PR domain zinc finger protein 14 (PRDM14). [16]
Fluorouracil DMUM7HZ Approved Fluorouracil affects the expression of PR domain zinc finger protein 14 (PRDM14). [17]
Panobinostat DM58WKG Approved Panobinostat increases the expression of PR domain zinc finger protein 14 (PRDM14). [18]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of PR domain zinc finger protein 14 (PRDM14). [18]
Belinostat DM6OC53 Phase 2 Belinostat increases the expression of PR domain zinc finger protein 14 (PRDM14). [18]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of PR domain zinc finger protein 14 (PRDM14). [20]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of PR domain zinc finger protein 14 (PRDM14). [21]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.Mol Cancer Res. 2019 Jul;17(7):1468-1479. doi: 10.1158/1541-7786.MCR-18-1327. Epub 2019 Apr 23.
2 Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers.Carcinogenesis. 2014 Nov;35(11):2611-8. doi: 10.1093/carcin/bgu197. Epub 2014 Sep 18.
3 PRDM14 is overexpressed in chronic pancreatitis prior to pancreatic cancer.FEBS Open Bio. 2018 Sep 17;8(10):1733-1741. doi: 10.1002/2211-5463.12519. eCollection 2018 Oct.
4 PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.Clin Transl Oncol. 2020 Jul;22(7):1126-1137. doi: 10.1007/s12094-019-02239-z. Epub 2019 Nov 18.
5 PRDM14 is expressed in germ cell tumors with constitutive overexpression altering human germline differentiation and proliferation.Stem Cell Res. 2018 Mar;27:46-56. doi: 10.1016/j.scr.2017.12.016. Epub 2018 Jan 4.
6 High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer.Med Oncol. 2013;30(3):605. doi: 10.1007/s12032-013-0605-9. Epub 2013 May 21.
7 Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.Nat Genet. 2013 Jun;45(6):686-9. doi: 10.1038/ng.2635. Epub 2013 May 12.
8 PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro.Chin Med J (Engl). 2015 Feb 5;128(3):373-7. doi: 10.4103/0366-6999.150109.
9 Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.Schizophr Bull. 2019 Jun 18;45(4):824-834. doi: 10.1093/schbul/sby140.
10 Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.Nat Genet. 2017 Jul;49(7):1133-1140. doi: 10.1038/ng.3896. Epub 2017 Jun 12.
11 PRDM14 directly interacts with heat shock proteins HSP90 and glucose-regulated protein 78.Cancer Sci. 2018 Feb;109(2):373-383. doi: 10.1111/cas.13458. Epub 2017 Dec 28.
12 Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer.Methods Mol Biol. 2019;1974:233-243. doi: 10.1007/978-1-4939-9220-1_18.
13 The zinc finger SET domain gene Prdm14 is overexpressed in lymphoblastic lymphomas with retroviral insertions at Evi32.PLoS One. 2008;3(11):e3823. doi: 10.1371/journal.pone.0003823. Epub 2008 Nov 27.
14 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
15 Molecular characterization of a toxicological tipping point during human stem cell differentiation. Reprod Toxicol. 2020 Jan;91:1-13. doi: 10.1016/j.reprotox.2019.10.001. Epub 2019 Oct 7.
16 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
17 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Arch Toxicol. 2021 Aug;95(8):2691-2718. doi: 10.1007/s00204-021-03092-2. Epub 2021 Jun 20.
18 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
19 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
20 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
21 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.